Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MRTTSE:6034 -0.47%63 EBIT per Share is 円30.25 as of Mar. 2026. GuruFocus rates TSE:6034 with a GF Score™ of 63/100 and a GF Value™ of 円628.00 (Fairly Valued). The stock has 4 warning signs investors should review. Among 523 Healthcare Providers & Services companies, MRT ranks worse than 98.28% on this metric.
MRT's EBIT per Share for the
three
months ended in Mar. 2026 was 円-19.50.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円30.25.
During the past 3 years, the average EBIT per Share Growth Rate was -68.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for MRT's EBIT per Share or its related term are showing as below:
TSE:6034'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -68.3 Med: 20.35 Max: 286.8
Current: -68.3
During the past 12 years, the highest 3-Year average EBIT per Share Growth Rate of MRT was 286.80% per year. The lowest was -68.30% per year. And the median was 20.35% per year.
TSE:6034's 3-Year EBIT Growth Rate is ranked worse than 98.28% of 523
companies
in the Healthcare Providers & Services industry
Industry Median: 12
vs TSE:6034: -68.30
MRT's EBIT for the
three
months ended in Mar. 2026 was 円-107 Mil.
MRT (TSE:6034) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
MRT EBIT per Share Related Terms
MRT EBIT per Share Historical Data
* Premium members only.
The historical data trend for MRT's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円30.25
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MRT (TSE:6034) has a EBIT per Share of 円30.25 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on MRT and its competitors. According to the industry distribution chart, MRT ranks #514 out of 523 companies in the Healthcare Providers & Services industry, placing it in the top 98.3%.
Is MRT's EBIT per Share too high?
MRT's current EBIT per Share is 円30.25. Based on the distribution chart, MRT ranks #514 out of 523 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, MRT has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MRT's EBIT per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, MRT ranks #514 out of 523 companies for EBIT per Share. This places MRT in the lower half of its industry. The industry median EBIT per Share is 12.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.00, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on MRT and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MRT's current EBIT per Share is 円30.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MRT stock overvalued right now?
Based on GuruFocus' analysis, MRT (TSE:6034) is currently considered Fairly Valued. The stock's GF Value™ is 円628.00, compared to a current price of 円632.00 — trading 0.6% above its estimated fair value. The current EBIT per Share is 円30.25. MRT's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For MRT (TSE:6034), the current EBIT per Share is 円30.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MRT (TSE:6034) Overvalued in 2026?
Based on GuruFocus' analysis, MRT stock appears to be overvalued.
The current stock price of 円632.00 is trading 0.6% above its estimated GF Value™ of 円628.00.
GuruFocus considers MRT to be Fairly Valued.
Key valuation signals for TSE:6034:
EBIT per Share: 円30.25
GF Value™: 円628.00 vs. price of 円632.00 (0.6% above fair value)
No single metric tells the full story. See the TSE:6034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MRT Inc engages in the business of medical personnel placement services through the Internet. It provides part-time and full-time physician referral services through the physician referral site, as well as part-time job referral, job change introduction services to nurses, pharmacists, clinical laboratory technicians, clinical engineers, and radiologists. Further, the company engages in the research and development of analytical and analytical methods for various biological samples, such as microorganisms, blood, proteins, and genes; and research and development, manufacture, and sale of medical and medical examination equipment, and analytical instruments.
63GF Score
Get the complete analysis for TSE:6034
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6034 has been successfully added to your 
